Rapid Readout: Expert Perspectives on Multiple Sclerosis - Data from the 8th Joint ACTRIMS-ECTRIMS Meeting 2020 - Episode 12
AbbVie Submits NDA for ABBV-951, Periconceptional Folic Acid Supplementation Lowers Preterm Birth Risk, FDA Accepts NDA for Zavegepant
NeurologyLive® Friday 5 — May 27, 2022
Neurology on the Hill 2022: Takeaways and Progress
Erenumab Shows Effectiveness as Migraine Preventive in Those With Prior Treatment Failures